Product Code: FBI107396
Growth Factors of airway management devices Market
The global airway management devices market was valued at USD 2.13 billion in 2025 and is projected to grow to USD 2.23 billion in 2026, reaching USD 3.25 billion by 2034, reflecting a CAGR of 4.85% during the forecast period (2026-2034). North America dominated the market with a 47.1% share in 2025, driven by high R&D investments and the launch of advanced airway management technologies.
Airway management devices, including bag-valve masks, endotracheal tubes, and laryngoscopes, play a critical role in providing ventilation and restoring breathing in patients with airway obstruction. The rising prevalence of chronic conditions such as COPD, cancer, and chronic lung diseases has significantly contributed to the demand for these devices. According to the National Center for Biotechnology Information (NCBI, 2022), the global prevalence of COPD among people aged 40 and above is around 10.1%, while the American Lung Association (2020) reported that 12.5 million U.S. adults (5% of the population) were diagnosed with COPD, chronic bronchitis, or emphysema, with 148,512 deaths recorded due to COPD.
The increase in chronic disease prevalence has also amplified emergency and intensive care admissions globally. In the U.S., CDC data (2022) shows 16.2 million emergency department visits resulted in hospital admissions, with 2.3 million requiring critical care. This surge in emergency and inpatient care, coupled with rising surgical procedures and anesthetic interventions, has driven the adoption of airway management devices.
Market Trends
The adoption of airway management devices is particularly increasing among neonates, due to the rise in premature births. The WHO (2023) reported approximately 13.4 million premature births worldwide in 2020, representing more than 10% of all births. In the U.S., CDC (2022) data indicates 1 in 10 births is preterm, with a 4% increase in preterm birth rate from 2020 to 2021. Premature infants frequently experience breathing disorders, increasing the need for airway management. Advanced pediatric devices, such as Medtronic's SonarMed system, allow real-time monitoring of endotracheal tube positioning, reducing complications like unplanned extubations and improving outcomes.
Market Growth Factors
The market is further bolstered by joint ventures, start-ups, and R&D investments by key industry players. Companies like Medtronic, ICU Medical, and Teleflex Incorporated are expanding production capabilities and launching innovative devices. For example, ICU Medical's acquisition of Smiths Medical in 2022 expanded its portfolio in airway management and infusion devices, while LifeMech's A-VS resuscitator received FDA approval in 2020, supporting emergency respiratory care during COVID-19. These investments in technologically advanced devices are anticipated to propel market growth across emerging nations.
Market Restraints
Despite growing demand, complications associated with device use can limit adoption. Intubation and airway devices carry risks such as regurgitation, aspiration, vascular compression, trauma, and nerve injury. According to NCBI (2021), tracheostomy bleeding occurs in 0.6-5% of cases globally, and NCBI (2023) reports cardiovascular instability, hypoxemia, and cardiac arrest rates of 42.6%, 9.3%, and 3.1%, respectively, linked to airway devices. Pediatric laryngeal masks may also cause soft-tissue trauma, vomiting, and airway restriction, highlighting the need for cautious usage.
Market Segmentation
By Type:
- Infraglottic airway management devices led the market with 55.46% share in 2026, driven by chronic respiratory disease prevalence and ICU usage. Innovations such as Ambu VivaSight 2 DLT with a built-in camera enhance clinical efficiency.
- Supraglottic devices are projected to grow at a higher CAGR due to rising investments in single-use devices.
By Application:
- Anesthesia dominates with 59.07% share in 2026, generating USD 1,261.3 million in 2025, fueled by increasing surgical procedures.
- Emergency medicine is projected to register higher growth due to rising hospital visits and trauma incidents.
By End-User:
- Hospitals & ASCs accounted for 78.56% share in 2026.
- Homecare is expanding due to increasing geriatric populations with chronic respiratory conditions, particularly post-COVID-19.
Regional Insights
- North America: USD 1.01 billion (2025), projected USD 1.05 billion (2026), driven by new device launches and collaborations. U.S. market: USD 0.84 billion (2026).
- Europe: USD 0.67 billion (2025), USD 0.71 billion (2026), CAGR 5.6%. UK: USD 0.05 billion; Germany: USD 0.19 billion (2026).
- Asia Pacific: USD 0.3 billion (2025), USD 0.31 billion (2026), strong CAGR, led by China and India.
- Latin America: USD 0.1 billion (2025-2026).
- Middle East & Africa: USD 0.05-0.06 billion (2025-2026).
Key Companies & Developments
Prominent players include Medtronic (Ireland), Teleflex Incorporated (U.S.), KARL STORZ (Germany), ICU Medical (U.S.), Convatec (U.K.), Ambu A/S (Denmark), and Intersurgical Ltd (U.K.). Recent developments include:
- June 2023: Morf Nasal Mask launch.
- Jan 2022: Intersurgical's acquisition of Pulmodyne, expanding U.S. and global reach.
- May 2021: Teleflex acquisition of non-invasive ventilation products.
- March 2021: Convatec acquisition of Cure Medical.
Conclusion
The global airway management devices market is poised for steady growth, driven by rising chronic respiratory disorders, increasing surgical and emergency procedures, technological advancements, and expanding applications in neonatal care. While complications associated with device usage remain a restraint, strategic investments, product innovations, and regional expansion efforts by key players are expected to propel the market to USD 3.25 billion by 2034.
Segmentation By Type
- Infraglottic Airway Management Devices
- Endotracheal Tubes
- Tracheostomy Tubes
- Supraglottic Airway Management Devices
- Oropharyngeal Airways (OPAS)
- Laryngeal Mask Airways (LMAS)
- Nasopharyngeal Airways
- Laryngoscopes
- Others
By Application
- Anesthesia
- Emergency Medicine
- Others
By End User
- Hospitals & ASCs
- Home care
- Others
By Region
- North America (By Type, Application, End User and Country)
- U.S. (By Application)
- Canada (By Application)
- Europe (By Type, By Application, End User and Country/Sub-Region)
- Germany (By Application)
- France (By Application)
- U.K. (By Application)
- Spain (By Application)
- Italy (By Application)
- Rest of Europe (By Application)
- Asia Pacific (By Type, Application, End User and Country/Sub-Region)
- China (By Application)
- India (By Application)
- Southeast Asia (By Application)
- Japan (By Application)
- Australia (By Application)
- Rest of Asia Pacific (By Application)
- Latin America (By Type, Application, End User and Country/Sub-Region)
- Mexico (By Application)
- Brazil (By Application)
- Rest of Latin America (By Application)
- Middle East & Africa (By Type, End User, and Country/Sub-Region)
- GCC (By Application)
- South Africa (By Application)
- Rest of MEA (By Application)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Chronic Obstructive Pulmonary Disease, By Key Countries/Sub-Region, 2025/2025
- 4.2. Prevalence of Asthma, By Key Countries, 2025/2025
- 4.3. New Product Launches, By Key Players
- 4.4. Key Industry Developments: Mergers, Partnerships, & Acquisitions, By Key Players
- 4.5. Impact of COVID-19 on Global Airway Management Devices Market
5. Global Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Infraglottic Airway Management Devices
- 5.1.1.1. Tracheostomy Tubes
- 5.1.1.2. Endotracheal Tubes (ETTS)
- 5.1.2. Supraglottic Airway Management Devices
- 5.1.2.1. Oropharyngeal Airways (OPAS)
- 5.1.2.2. Laryngeal Mask Airways (LMAS)
- 5.1.2.3. Nasopharyngeal Airways
- 5.1.3. Laryngoscopes
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Anesthesia
- 5.2.2. Emergency Medicine
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Hospitals & ASCs
- 5.3.2. Home Care
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Infraglottic Airway Management Devices
- 6.1.1.1. Tracheostomy Tubes
- 6.1.1.2. Endotracheal Tubes (ETTS)
- 6.1.2. Supraglottic Airway Management Devices
- 6.1.2.1. Oropharyngeal Airways (OPAS)
- 6.1.2.2. Laryngeal Mask Airways (LMAS)
- 6.1.2.3. Nasopharyngeal Airways
- 6.1.3. Laryngoscopes
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Anesthesia
- 6.2.2. Emergency Medicine
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Hospitals & ASCs
- 6.3.2. Home Care
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Infraglottic Airway Management Devices
- 7.1.1.1. Tracheostomy Tubes
- 7.1.1.2. Endotracheal Tubes (ETTS)
- 7.1.2. Supraglottic Airway Management Devices
- 7.1.2.1. Oropharyngeal Airways (OPAS)
- 7.1.2.2. Laryngeal Mask Airways (LMAS)
- 7.1.2.3. Nasopharyngeal Airways
- 7.1.3. Laryngoscopes
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Anesthesia
- 7.2.2. Emergency Medicine
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Hospitals & ASCs
- 7.3.2. Home Care
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.4.1. Germany
- 7.4.2. Spain
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. U.K.
- 7.4.6. Rest of Europe
8. Asia Pacific Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Infraglottic Airway Management Devices
- 8.1.1.1. Tracheostomy Tubes
- 8.1.1.2. Endotracheal Tubes (ETTS)
- 8.1.2. Supraglottic Airway Management Devices
- 8.1.2.1. Oropharyngeal Airways (OPAS)
- 8.1.2.2. Laryngeal Mask Airways (LMAS)
- 8.1.2.3. Nasopharyngeal Airways
- 8.1.3. Laryngoscopes
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Anesthesia
- 8.2.2. Emergency Medicine
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Hospitals & ASCs
- 8.3.2. Home Care
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Southeast Asia
- 8.4.4. Japan
- 8.4.5. Australia
- 8.4.6. Rest of Asia Pacific
9. Latin America Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Infraglottic Airway Management Devices
- 9.1.1.1. Tracheostomy Tubes
- 9.1.1.2. Endotracheal Tubes (ETTS)
- 9.1.2. Supraglottic Airway Management Devices
- 9.1.2.1. Oropharyngeal Airways (OPAS)
- 9.1.2.2. Laryngeal Mask Airways (LMAS)
- 9.1.2.3. Nasopharyngeal Airways
- 9.1.3. Laryngoscopes
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Anesthesia
- 9.2.2. Emergency Medicine
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Hospitals & ASCs
- 9.3.2. Home Care
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Infraglottic Airway Management Devices
- 10.1.1.1. Tracheostomy Tubes
- 10.1.1.2. Endotracheal Tubes (ETTS)
- 10.1.2. Supraglottic Airway Management Devices
- 10.1.2.1. Oropharyngeal Airways (OPAS)
- 10.1.2.2. Laryngeal Mask Airways (LMAS)
- 10.1.2.3. Nasopharyngeal Airways
- 10.1.3. Laryngoscopes
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Anesthesia
- 10.2.2. Emergency Medicine
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Hospitals & ASCs
- 10.3.2. Home Care
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Medtronic
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Teleflex Incorporated
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. KARL STORZ SE & Co. KG
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. ICU Medical
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Convatec Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Ambu A/S
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Intersurgical Ltd
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. VBM Medizintechnik GmbH
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. VYAIRE MEDICAL, INC.
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Flexicare (Group) Limited
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)